A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder

BACKGROUND AND OBJECTIVE: Attention-deficit/hyperactivity disorder is a neurodevelopmental disorder that typically begins in childhood and often persists into adulthood. Recent phase III trials have demonstrated the efficacy and safety of viloxazine extended-release capsules (viloxazine ER; Qelbree(...

Descripción completa

Detalles Bibliográficos
Autores principales: Nasser, Azmi, Hull, Joseph T., Chaturvedi, Soumya A., Liranso, Tesfaye, Odebo, Oyinkansola, Kosheleff, Alisa R., Fry, Nicholas, Cutler, Andrew J., Rubin, Jonathan, Schwabe, Stefan, Childress, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328182/
https://www.ncbi.nlm.nih.gov/pubmed/35896943
http://dx.doi.org/10.1007/s40263-022-00938-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328182/
https://www.ncbi.nlm.nih.gov/pubmed/35896943
http://dx.doi.org/10.1007/s40263-022-00938-w

Ejemplares similares